Ultra-Hypofractionated Re-Irradiation with Anti-PD-1 Immunotherapy for Locoregionally Recurrent (after Radical Chemo-Radiotherapy) Non-Small Cell Lung Cancer
Article in Cancers (October 2023)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Reirradiation with stereotactic body radiotherapy for primary or secondary lung malignancies: Tumor control probability and safety analyses
Article in Radiotherapy and Oncology (July 2023)
NSCLC Patients Achieving Long-term Progression-free Survival With Docetaxel Plus Ramucirumab: A Retrospective Study.
Article in Cancer Diagnosis & Prognosis (March 2023)